All In MedTech

FDA Clearance Tracker · P920047

EPT-1000 CARDIAC ABLATION SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Oct 28, 1994 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Oct 28, 1994

Approved

Time to decision

760 days

Received Sep 28, 1992. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P920047
Device name
EPT-1000 CARDIAC ABLATION SYSTEM
Applicant location
St Paul, MN
Received
Sep 28, 1992
Decided
Oct 28, 1994
Decision
Approved
Supplements
133 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code LPB

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code LPB (Cardiac ablation percutaneous catheter).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.